Chaudhari et al., 2011 - Google Patents
Evaluation of binding properties of Boswellia Serrata Roxb. gum in tablet formulation.Chaudhari et al., 2011
- Document ID
- 18113321682937527687
- Author
- Chaudhari S
- Patil P
- Deshmukh T
- Tekade B
- Patil V
- Publication year
- Publication venue
- Journal of Pharmaceutical Education & Research
External Links
Snippet
The objective was to evaluate the binding property of Boswellia serrata gum. The gum was isolated from oleo-gum resin of Boswellia serrata Roxb. Physicochemical characteristics of gum were studied. Different formulations of tablets using Boswellia serrata gum were …
- 229920000591 gum 0 title abstract description 56
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/72—Cosmetic or similar toilet preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/26—Cellulose ethers
- C08L1/28—Alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hasnain et al. | Extraction and characterization of cashew tree (Anacardium occidentale) gum; use in aceclofenac dental pastes | |
| CN107428847B (en) | Soluble ester cellulose ether with low degree of neutralization | |
| Jaiswal et al. | Physicochemical properties and release characteristics of starches from seeds of Indian Shahi Litchi | |
| WO2016015813A1 (en) | Directly compressible composition containing micro-crystalline cellulose | |
| Jena et al. | Determination of efficacy of a natural tablet binder: characterization and in-vitro release study | |
| Chaudhari et al. | Evaluation of binding properties of Boswellia Serrata Roxb. gum in tablet formulation. | |
| CN107636019B (en) | Soluble ester cellulose ether | |
| Patel et al. | Assessment of various pharmaceutical excipient properties of natural Moringa oleifera gum [Mucoadhesion, disintegration, binder]. | |
| Kumar et al. | Extraction, isolation and evaluation Trigonella foenum-graecum as mucoadhesive agent for nasal gel drug delivery | |
| Ghule et al. | Evaluation of Binding Properties of Evaluation of Binding Properties of Eulophia campestris Wall. Mucilage all. Mucilage | |
| Reena et al. | Enhancement of solubility and dissoultion rate of domperidone using cogrinding and kneading technique | |
| Mohammed et al. | Formulation and evaluation of flurbiprofen fast disintegrating tablets using natural superdisintegrants | |
| Deshmukh et al. | Evaluation of binding properties of Butea monosperma Lam, Gum in tablet formulation | |
| Rao et al. | Design and characterization of sustained release aceclofenac matrix tablets containing tamarind seed polysaccharide | |
| Sharma et al. | Comparison of various natural superdisintegrants in the formulation of fast dissolving carvedilol tablet | |
| Ramu et al. | Preliminary investigation of patchaippasali mucilage (Basella alba) as tablet binder | |
| CN109833304B (en) | Composition for solid preparation, solid preparation and method for producing same | |
| Kumar et al. | Evaluation of disintegrating properties of Abelmoschus esculentus mucilage | |
| Layas et al. | Extraction and evaluation of'Lepidium sativum'and flax seeds mucilage as a pharmaceutical granulation binder | |
| Singh et al. | Evaluation of Cassia fistula Linn. seed mucilage in tablet formulations | |
| Abuelrakha et al. | Extraction and evaluation of Linseed mucilage as binding agent in prednisolone tablet 20 mg | |
| Ikechukwu et al. | Physicochemical characterisation of Irvingia wombolu gum in tramadol encapsulated granules | |
| Meko et al. | Investigation into the use of acid modified millet (Pennisetum glaucum) starch mucilage as tablet binder | |
| Singh et al. | Pharmaceutical characterization of Cassia tora of seed mucilage in tablet formulations | |
| Eraga et al. | Formulation of sustained release diclofenac sodium tablets using a blend of hydrophobic and hydrophilic polymers |